Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost vs Latanoprost in Glaucoma/Ocular Hypertension
NCT00541242Phase 4Completed
- Sponsor
- Allergan
- Start
- Dec 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bimatoprost in Glaucoma and ocular hypertension (2 arms), sponsored by Allergan. Primary endpoint: Change From Baseline in Mean Diurnal Intraocular Pressure (IOP) at Week 18. Started Dec 2007; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00541242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541242.